C41Navigating PrEP use and pregnancy: perspectives among adolescent girls and young women (AGYW) in Tshwane, South AfricaE-posterPrEP and pregnant women
C41CAP016 PrEP in pregnancy - a phase 2b open-label randomised control safety study of daily oral TDF/FTC when used as pre-exposure prophylaxis for HIV prevention in pregnant and lactating womenE-posterPrEP and pregnant women
C42Preference for long-acting injectable pre-exposure prophylaxis among transgender women clients of the Tangerine Clinic in Bangkok, ThailandOral abstract session with live Q&APrEP and transwomen
C53Changes in HIV outcomes and progress towards epidemic control from 2016 to 2020 in Lesotho: comparing results from two nationally representative surveysE-posterPrevention among people living with HIV
C34Evaluation of isoniazid preventive therapy received by children living with HIV in NigeriaE-posterPrevention for co-morbidities (e.g., TB, viral hepatitis)
C34Human Papilloma Virus (HPV) vaccination uptake in HIV patients: challenges during COVID-19 pandemic in Michigan, USAE-posterPrevention for co-morbidities (e.g., TB, viral hepatitis)
C34Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: an opportunity to achieve dual elimination of HIV and viral hepatitis by 2030E-posterPrevention for co-morbidities (e.g., TB, viral hepatitis)
C56The association of exposure to DREAMS combination HIV prevention on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa: a cohort studyOn-demand oral abstract sessionPrevention in adolescents
C56Preparing pediatric providers to PrEP: provider utilization of a best practice advisory and association with PrEP prescription ratesE-posterPrevention in adolescents
C56Effectiveness of strategies for generating demand for PrEP and combination prevention among adolescent´s men who have sex with men and transgender women in BrazilE-posterPrevention in adolescents
661 - 670 of 870 items